GHIT supports further development of a new asexual blood-stage malaria vaccine candidate

Goal of new project is to further advance the development of a new vaccine candidate based on the PfRipr5 protein of Plasmodium falciparum.

The three project partners -Ehime University, Japan, iBET, Portugal, and EVI, Germany- will test and compare different expression systems for the antigen and subsequently test the immunogenicity of the antigen formulated with different adjuvants in different model systems.

See also press release on GHIT webpage.